Oppenheimer Asset Management Inc. Novo Cure LTD Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$63.98 - $85.37 $26,615 - $35,513	-416 Reduced 9.59%	3,924 $287,000
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $6,187 - $8,150	-91 Reduced 2.05%	4,340 $330,000
Q2 2022 Aug 08, 2022	SELL	$56.6 - $89.9 $10,244 - $16,271	-181 Reduced 3.92%	4,431 $308,000
Q1 2022 May 12, 2022	SELL	$60.15 - $84.52 $2,345 - $3,296	-39 Reduced 0.84%	4,612 $382,000
Q4 2021 Feb 02, 2022	SELL	$75.08 - $121.99 $15,916 - $25,861	-212 Reduced 4.36%	4,651 $349,000
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $27,764 - $46,497	-239 Reduced 4.68%	4,863 $565,000
Q2 2021 Aug 03, 2021	SELL	$130.4 - $225.58 $17,864 - $30,904	-137 Reduced 2.62%	5,102 $1.13 Million
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $15,389 - $23,581	-124 Reduced 2.31%	5,239 $692,000
Q4 2020 Feb 11, 2021	SELL	$112.16 - $174.14 $40,489 - $62,864	-361 Reduced 6.31%	5,363 $928,000
Q3 2020 Nov 13, 2020	SELL	$58.05 - $111.31 $7,546 - $14,470	-130 Reduced 2.22%	5,724 $637,000
Q2 2020 Aug 11, 2020	BUY	$57.2 - $74.41 $3,603 - $4,687	63 Added 1.09%	5,854 $347,000
Q1 2020 May 08, 2020	BUY	$57.05 - $95.75 $97,042 - $162,870	1,701 Added 41.59%	5,791 $390,000
Q4 2019 Feb 07, 2020	BUY	$68.3 - $93.8 $109,006 - $149,704	1,596 Added 63.99%	4,090 $345,000
Q3 2019 Oct 31, 2019	SELL	$61.86 - $97.8 $3,773 - $5,965	-61 Reduced 2.39%	2,494 $187,000
Q2 2019 Aug 09, 2019	SELL	$42.22 - $63.23 $18,323 - $27,441	-434 Reduced 14.52%	2,555 $162,000
Q1 2019 Apr 24, 2019	SELL	$31.96 - $56.12 $39,694 - $69,701	-1,242 Reduced 29.35%	2,989 $144,000
Q4 2018 Jan 30, 2019	BUY	$28.72 - $52.63 $121,514 - $222,677	4,231 New	4,231 $142,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$215 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$210 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$140 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$76.4 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$53.7 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account